()-Epigallocatechin-3-Gallate Inhibits EBV Lytic Replication via Targeting LMP1-Mediated MAPK Signal Axes
Authors:
Open Access
- 7 September 2021
- journal article
- research article
- Published by Tech Science Press in Oncology Research
- Vol. 28 (7) , 763-778
Abstract
EpsteinBarr virus (EBV)-encoded latent membrane protein 1 (LMP1) plays an important oncogenic role in the viral latent infection. Recently, increasing evidence indicates that the high expression of LMP1 during EBV lytic cycle is related to the viral lytic replication. However, the mechanism by which LMP1 regulates EBV lytic replication remains unclear. ()-Epigallocatechin-3-gallate (EGCG) prevents carcinogenesis by directly targeting numerous membrane proteins and effectively inhibits EBV lytic cascade. Here, we demonstrated that LMP1 promotes EBV lytic replication through the downstream signal molecules MAPKs, including ERKs, p38, and JNKs. LMP1 induces the phosphorylation of p53 through MAPKs to enhance the ability of wild-type p53 (wt-p53) to activate expression of BZLF1 gene, while the JNKs/c-Jun signal axis appears to be involved in EBV lytic replication induced by LMP1 in p53 mutant manner. We provided the first evidence that EGCG directly targets the viral membrane LMP1 (Kd=0.36 M,n=1) using fluorescence quenching, isothermal titration calorimetry (ITC) assay, and CNBR-activated Sepharose 4B pull-down affinity chromatography. Furthermore, we revealed that EGCG inhibits EBV lytic replication via suppressing LMP1 and thus blocking the downstream MAPKs/wt-p53 signal axis in AGS-EBV cells and JNKs/c-Jun signal axis in p53 mutant B95.8 cells. Our study, for the first time, reports the binding and inhibitory efficacy of EGCG to the LMP1, which is a key oncoprotein encoded by EBV. These findings suggest the novel function of LMP1 in the regulation of EBV lytic cycle and reveal the new role of EGCG in EBV-associated malignancies through suppressing viral reactivation.Keywords
This publication has 73 references indexed in Scilit:
- Down-Regulation of EBV-LMP1 Radio-Sensitizes Nasal Pharyngeal Carcinoma Cells via NF-κB Regulated ATM ExpressionPLOS ONE, 2011
- Evidence for DNA Hairpin Recognition by Zta at the Epstein-Barr Virus Origin of Lytic ReplicationJournal of Virology, 2010
- AP-1 homolog BZLF1 of Epstein–Barr virus has two essential functions dependent on the epigenetic state of the viral genomeProceedings of the National Academy of Sciences, 2009
- Suberoylanilide hydroxamic acid induces viral lytic cycle in Epstein‐Barr virus‐positive epithelial malignancies and mediates enhanced cell deathInternational Journal of Cancer, 2009
- Epigallocatechin 3-Gallate and Green Tea Catechins: United They Work, Divided They FailCancer Prevention Research, 2009
- Cancer prevention by tea: animal studies, molecular mechanisms and human relevanceNature Reviews Cancer, 2009
- MDM2-Dependent Inhibition of p53 Is Required for Epstein-Barr Virus B-Cell Growth Transformation and Infected-Cell SurvivalJournal of Virology, 2009
- Critical Role of p53 in Histone Deacetylase Inhibitor-Induced Epstein-Barr Virus Zta ExpressionJournal of Virology, 2008
- Targeting Receptor Tyrosine Kinases for Chemoprevention by Green Tea Catechin, EGCGInternational Journal of Molecular Sciences, 2008
- Epstein-Barr Virus Infection Alters Cellular Signal Cascades in Human Nasopharyngeal Epithelial CellsNeoplasia, 2006